Schabet M - Search Results

1

CD95 ligand-induced apoptosis of human medulloblastoma cells.

Weller M, Schuster M, Pietsch T, Schabet M. Weller M, et al. Among authors: schabet m. Cancer Lett. 1998 Jun 19;128(2):121-6. doi: 10.1016/s0304-3835(98)00019-6. Cancer Lett. 1998. PMID: 9683272

2

Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.

Weller M, Trepel M, Grimmel C, Schabet M, Bremen D, Krajewski S, Reed JC. Weller M, et al. Among authors: schabet m. Neurol Res. 1997 Oct;19(5):459-70. Neurol Res. 1997. PMID: 9329022

3

Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.

Glaser T, Winter S, Groscurth P, Safayhi H, Sailer ER, Ammon HP, Schabet M, Weller M. Glaser T, et al. Among authors: schabet m. Br J Cancer. 1999 May;80(5-6):756-65. doi: 10.1038/sj.bjc.6690419. Br J Cancer. 1999. PMID: 10360653 Free PMC article.

4

Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.

Weller M, Stevens A, Sommer N, Schabet M, Wiethölter H. Weller M, et al. Among authors: schabet m. Cancer. 1992 Mar 15;69(6):1475-80. doi: 10.1002/1097-0142(19920315)69:6<1475::aid-cncr2820690627>3.0.co;2-d. Cancer. 1992. PMID: 1371713

5

Animal model of human medulloblastoma: clinical, magnetic resonance imaging, and histopathological findings after intra-cisternal injection of MHH-MED-1 cells into nude rats.

Schabet M, Martos J, Buchholz R, Pietsch T. Schabet M, et al. Med Pediatr Oncol. 1997 Aug;29(2):92-7. doi: 10.1002/(sici)1096-911x(199708)29:2<92::aid-mpo5>3.0.co;2-m. Med Pediatr Oncol. 1997. PMID: 9180909

6

Humoral immune response to p53 in malignant glioma.

Weller M, Bornemann A, Ständer M, Schabet M, Dichgans J, Meyermann R. Weller M, et al. Among authors: schabet m. J Neurol. 1998 Mar;245(3):169-72. doi: 10.1007/s004150050199. J Neurol. 1998. PMID: 9553848

7

BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study.

Rieger L, Weller M, Bornemann A, Schabet M, Dichgans J, Meyermann R. Rieger L, et al. Among authors: schabet m. J Neurol Sci. 1998 Feb 18;155(1):68-75. doi: 10.1016/s0022-510x(97)00277-3. J Neurol Sci. 1998. PMID: 9562325

8

New aspects of immunotherapy of leptomeningeal metastasis.

Herrlinger U, Weller M, Schabet M. Herrlinger U, et al. Among authors: schabet m. J Neurooncol. 1998 Jun-Jul;38(2-3):233-9. doi: 10.1023/a:1005948722912. J Neurooncol. 1998. PMID: 9696377 Review.

9

Topotecan-based combination chemotherapy for human malignant glioma.

Schmidt F, Schuster M, Streffer J, Schabet M, Weller M. Schmidt F, et al. Among authors: schabet m. Anticancer Res. 1999 Mar-Apr;19(2A):1217-21. Anticancer Res. 1999. PMID: 10368678

10

Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.

Herrlinger U, Schabet M, Brugger W, Kortmann RD, Kanz L, Bamberg M, Dichgans J, Weller M. Herrlinger U, et al. Among authors: schabet m. Cancer. 2001 Jan 1;91(1):130-5. doi: 10.1002/1097-0142(20010101)91:1<130::aid-cncr17>3.0.co;2-8. Cancer. 2001. PMID: 11148569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters